ZIOPHARM Oncology Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Okay. Good morning, and thanks for tuning in to the JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst.
Our next presenting company this morning is Ziopharm Oncology. And here to tell us a little bit about the company. It's my pleasure to welcome Dr. Laurence Cooper, the CEO of the company.
Just to note, there will be a Q&A after the presentation. So feel free to submit a question, just click the Ask a Question icon.
With that, Lauren, thanks for sharing some of your time with us.
& -
Thank you, Eric, and everybody and for hosting such a great event in a virtual format. And I really appreciate everybody's efforts. So we're excited to be here to talk about our story and to engage with you all. Just as a reminder, on Slide 2 is the forward-looking statement. And -- so we'll go now to Slide 3. And I'd like to cover 4 topics today, which you can see on the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |